BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 28388307)

  • 1. Cytomegalovirus infection in lung transplant recipients.
    Almaghrabi RS; Omrani AS; Memish ZA
    Expert Rev Respir Med; 2017 May; 11(5):377-383. PubMed ID: 28388307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of the prevention strategies on the indirect effects of CMV infection in solid organ transplant recipients.
    Roman A; Manito N; Campistol JM; Cuervas-Mons V; Almenar L; Arias M; Casafont F; del Castillo D; Crespo-Leiro MG; Delgado JF; Herrero JI; Jara P; Morales JM; Navarro M; Oppenheimer F; Prieto M; Pulpón LA; Rimola A; Serón D; Ussetti P;
    Transplant Rev (Orlando); 2014 Apr; 28(2):84-91. PubMed ID: 24602805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytomegalovirus infections in renal, heart, heart-lung and liver transplantation.
    Pollard RB
    Pediatr Infect Dis J; 1988 May; 7(5 Suppl):S97-102. PubMed ID: 2456512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment and prevention of cytomegalovirus infection in heart and lung transplantation: an update.
    Potena L; Solidoro P; Patrucco F; Borgese L
    Expert Opin Pharmacother; 2016 Aug; 17(12):1611-22. PubMed ID: 27340928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune-based monitoring for cytomegalovirus infection in solid organ transplantation: is it ready for clinical primetime?
    Melendez D; Razonable RR
    Expert Rev Clin Immunol; 2014 Sep; 10(9):1213-27. PubMed ID: 25081073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Special considerations in the management of cytomegalovirus infection in pediatric solid organ transplant recipients].
    Rumbao J; Frauca E
    Enferm Infecc Microbiol Clin; 2011 Dec; 29 Suppl 6():70-3. PubMed ID: 22541928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytomegalovirus in transplantation - challenging the status quo.
    Fishman JA; Emery V; Freeman R; Pascual M; Rostaing L; Schlitt HJ; Sgarabotto D; Torre-Cisneros J; Uknis ME
    Clin Transplant; 2007; 21(2):149-58. PubMed ID: 17425738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Everolimus-based immunosuppressive regimens in lung transplant recipients: impact on CMV infection.
    Rittà M; Costa C; Solidoro P; Sidoti F; Libertucci D; Boffini M; Rinaldi M; Baldi S; Cavallo R
    Antiviral Res; 2015 Jan; 113():19-26. PubMed ID: 25446337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevention of cytomegalovirus disease in lung transplantation].
    Gavaldà J; Monforte V; Len Ó
    Enferm Infecc Microbiol Clin; 2011 Dec; 29 Suppl 6():46-51. PubMed ID: 22541923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytomegalovirus in hematopoietic stem cell transplant recipients - management of infection.
    Locatelli F; Bertaina A; Bertaina V; Merli P
    Expert Rev Hematol; 2016 Nov; 9(11):1093-1105. PubMed ID: 27690683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infectious complications in pulmonary allograft recipients.
    Dauber JH; Paradis IL; Dummer JS
    Clin Chest Med; 1990 Jun; 11(2):291-308. PubMed ID: 2189664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infection and reactivation with cytomegalovirus strains in lung transplant recipients.
    Smyth RL; Sinclair J; Scott JP; Gray JJ; Higenbottam TW; Wreghitt TG; Wallwork J; Borysiewicz LK
    Transplantation; 1991 Sep; 52(3):480-2. PubMed ID: 1654605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and immunologic aspects of cytomegalovirus infection in solid organ transplant recipients.
    Rowshani AT; Bemelman FJ; van Leeuwen EM; van Lier RA; ten Berge IJ
    Transplantation; 2005 Feb; 79(4):381-6. PubMed ID: 15729162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diversity of antiviral-resistant human cytomegalovirus in heart and lung transplant recipients.
    Iwasenko JM; Scott GM; Naing Z; Glanville AR; Rawlinson WD
    Transpl Infect Dis; 2011 Apr; 13(2):145-53. PubMed ID: 21070537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation and significance of cytomegalovirus-specific cellular immune response in lung transplant recipients.
    Costa C; Astegiano S; Terlizzi ME; Sidoti F; Curtoni A; Solidoro P; Baldi S; Bergallo M; Cavallo R
    Transplant Proc; 2011 May; 43(4):1159-61. PubMed ID: 21620077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary Cytomegalovirus Replication in Renal Transplant Patients with Late Onset Pneumonitis.
    Königshausen E; Hengel H; Adams O; Bry H; Steiner S; Priegnitz C; Hansen A; Sellin L; Rump LC; Voiculescu A
    Ann Transplant; 2016 Apr; 21():235-40. PubMed ID: 27097869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric transplantation case conference: Update on cytomegalovirus.
    Pellett Madan R; Allen UD; Green M; Höcker B; Michaels MG; Varela-Fascinetto G; Danziger-Isakov L;
    Pediatr Transplant; 2018 Nov; 22(7):e13276. PubMed ID: 30203626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on viral infections in lung transplantation.
    Uhlin M; Mattsson J; Maeurer M
    Curr Opin Pulm Med; 2012 May; 18(3):264-70. PubMed ID: 22388587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytomegalovirus infection in the liver transplant recipient. Epidemiology, pathogenesis, and clinical management.
    Rubin RH
    Clin Liver Dis; 1997 Aug; 1(2):439-52, x. PubMed ID: 15562577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence, Risk Factors and Outcomes of Delayed-onset Cytomegalovirus Disease in a Large Retrospective Cohort of Lung Transplant Recipients.
    Santos CA; Brennan DC; Yusen RD; Olsen MA
    Transplantation; 2015 Aug; 99(8):1658-66. PubMed ID: 25675196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.